Xuhao Ni

1.3k citations
16 papers · 967 indexed · 1 hit paper · h-index 12
Topics
Immune Cell Function and Interaction (5 papers)Adenosine and Purinergic Signaling (3 papers)Peptidase Inhibition and Analysis (3 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Xuhao Ni

16 papers receiving 961 citations

Hit Papers

Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 +...2018202620202023201850100150200

Peers

Xuhao Ni
Comparison fields: 5 of 82
  • Immunology 411
  • Molecular Biology 391
  • Oncology 273
  • Cancer Research 251
  • Cell Biology 119
Replace Hao Lu with:
Hao Lu China
Honghong Sun China
Muhammad Baghdadi Japan
Howard R. Seay United States
Y. Jeffrey Chiang United States
Qi-Jing Li United States
Kyle K. Payne United States
Je-In Youn United States
Gaia Barisione Italy
Xuhao Ni relative to Hao Lu China Hao Lu's profile →
Citations per field
00.5×
Hao Lu · 1×
Citations per year

Countries citing papers authored by Xuhao Ni

Since Specialization
Citations

This map shows the geographic impact of Xuhao Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuhao Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuhao Ni more than expected).

Fields of papers citing papers by Xuhao Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuhao Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuhao Ni. The network helps show where Xuhao Ni may publish in the future.

Co-authorship network of co-authors of Xuhao Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Xuhao Ni. A scholar is included among the top collaborators of Xuhao Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuhao Ni. Xuhao Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 11
2 19
3 48
4 40
5 22
6 168
7 49
8 23
9
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cellsbreakdown →
244
10 10
11 159
12 77
13 51
14 1
15 9
16 36

About Xuhao Ni

Xuhao Ni is a scholar working on Physiology, Cancer Research and Immunology, having authored 16 papers that have together received 967 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Adenosine and Purinergic Signaling (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Immunology (411 citations), Physiology (76 citations) and Cancer Research (251 citations). Xuhao Ni has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Fan Pan, Ling Lu, Cynthia A. Zahnow, Gregg L. Semenza, Debangshu Samanta, Youngrok Park, Huili Li, Edward Gabrielson, Xuehao Wang and Jian Gu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026